RBC Capital reiterates Corteva stock rating on seed spinoff outlook
Covered in this story
What has happened since
- Corteva is up 6.1% since this was published, 34 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Corteva
- RBC Capital Markets: $14.4 → $17 by Oct 2027 · Outperform via Investing.com
- Oppenheimer: $14.4 → $17 by Oct 2027 · Outperform via Investing.com
- Goldman Sachs: $14.4 → $20 by Oct 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $CTVA yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Corteva →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.